微生物是治疗性喘方法的小助手和供应商
Sebastian Reuter1, Jonas Raspe2, Christian Taube2
1Department of Pulmonary Medicine, University Hospital Essen-Ruhrlandklinik, Tüschener Weg 40, 45239, Essen, Germany. sebastian.reuter@rlk.uk-essen.de.
Respiratory research
|January 13, 2024
概括
喘治疗正在发展,超越了传统方法. 利用调节性T细胞 (Tregs) 和微生物疗法为控制呼吸道炎症和预防喘恶化提供了新的途径.
科学领域:
- 免疫学和呼吸系统医学
- 微生物组研究 微生物组研究
- 治疗开发的治疗方法
背景情况:
- 喘是一种复杂的炎症性肺病,具有多种表型和内型,具有挑战性的当前治疗方法.
- 像皮质类固醇这样的现有疗法在严重的喘病例中效果较差.
- 需要新的方法来改善喘控制和减少恶化.
研究的目的:
- 探索新的喘治疗策略,专注于基于免疫的干预措施.
- 研究调控性T细胞 (Tregs) 在控制喘病理方面的潜力.
- 检查微生物相关的治疗炎症性肺部疾病的方法.
主要方法:
- 关于喘表型,内型和治疗限制的当前文献的综述.
- 对调节性T细胞 (Tregs) 在免疫平衡和炎症控制中的作用的分析.
- 探索微生物与宿主相互作用及其在炎症性疾病中的治疗影响.
主要成果:
- 调节性T细胞 (Tregs) 显示出控制2型高和2型低炎症的潜力.
- 微生物疗法,包括共生性和致病性微生物,表现出免疫抑制性质.
- 细菌与宿主之间的相互作用为炎症条件的治疗开发提供了有希望的途径.
结论:
- 通过Tregs刺激内源性抗炎反应是喘的一个有希望的策略.
- 微生物相关疗法为炎症性肺部疾病提供了新的治疗可能性.
- 对Tregs和微生物组调节的进一步研究可能会导致改善喘管理.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Leukotriene Modifiers
302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
302
Inhaled Medications
271
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
271


